Literature DB >> 1235

Cytochrome P-450 measurement in rat liver homogenate and microsomes. Its use for correction of microsomal losses incurred by differential centrifugation.

J G Joly, C Doyon, Y Peasant.   

Abstract

Cytochrome P-450 was assayed in rat liver homogenates and microsomes in order to calculate microsomal recoveries and correct for losses during ultracentrifugation or sedimentation in presence of CaCl2. The values obtained for corrected microsomal protein in untreated female Sprague-Dawley rats were between 40 and 50 mg/g of liver. The assay of cytochrome P-450 in liver homogenate is accurate enough to calculate a reproducible recovery factor. The value of the method lies in its rapidity, its capacity to correct over a wide range of losses, and its capacity to yield reliable values of the total microsomal protein mass. The limits of this method include overestimation of homogenate cytochrome P-450 and inability to correct for nonmicrosomal protein contamination. Overestimation of cytochrome P-450 can be corrected by measuring the difference in absorbance between 450 and 510 nm with the extinction coefficient of 100 mM-1cm-1. To be accurate, cytochrome P-450 determination on microsomes must be done at protein concentrations of about 3 mg/ml. The error inherent to the method may be kept constant and minimal. The use of correction for microsomal losses is recommended in order to obtain uniformity between results from various laboratories and adequate correlation with in vivo studies of microsomal functions.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1235

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  7 in total

1.  Parameterization of Microsomal and Cytosolic Scaling Factors: Methodological and Biological Considerations for Scalar Derivation and Validation.

Authors:  Michael J Doerksen; Robert S Jones; Michael W H Coughtrie; Abby C Collier
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2020-12-19       Impact factor: 2.441

Review 2.  Ontogeny of hepatic and renal systemic clearance pathways in infants: part II.

Authors:  Jane Alcorn; Patrick J McNamara
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

3.  Determination of a human hepatic microsomal scaling factor for predicting in vivo drug clearance.

Authors:  Nancy Hakooz; Kiyomi Ito; Helen Rawden; Helen Gill; Lynn Lemmers; Alan R Boobis; Robert J Edwards; David J Carlile; Brian G Lake; J Brian Houston
Journal:  Pharm Res       Date:  2006-02-28       Impact factor: 4.200

4.  Comparative physiologically based pharmacokinetics of hexobarbital, phenobarbital and thiopental in the rat.

Authors:  Y Igari; Y Sugiyama; S Awazu; M Hanano
Journal:  J Pharmacokinet Biopharm       Date:  1982-02

5.  Inhibition of liver regeneration by chronic alcohol administration.

Authors:  L Duguay; D Coutu; C Hetu; J G Joly
Journal:  Gut       Date:  1982-01       Impact factor: 23.059

6.  Effect of improved absorption on development of jejunoileal bypass-induced liver dysfunction in rats.

Authors:  J A Vanderhoof; M J Metz; D J Tuma; D L Antonson; M F Sorrell
Journal:  Dig Dis Sci       Date:  1980-08       Impact factor: 3.199

7.  Role of defunctionalized bowel in jejunoileal bypass-induced liver disease in rats.

Authors:  J A Vanderhoof; D J Tuma; M F Sorrell
Journal:  Dig Dis Sci       Date:  1979-12       Impact factor: 3.199

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.